Summary
This 8-K filing from Elevance Health, Inc. (formerly Anthem, Inc.) on November 29, 2018, primarily serves to update investors on full-year 2018 financial guidance. The company reaffirms its net income guidance, expecting it to be greater than $14.46 per share, with adjusted net income projected to be over $15.60 per share, excluding approximately $1.14 per share in net unfavorable items. This guidance remains consistent with figures previously reported in their third quarter earnings release. However, the company revised its medical membership guidance downwards. The anticipated year-end medical membership is now projected to be around 39.5 million, a decrease from previous expectations. This adjustment is attributed to the delayed launch of the Blue Cross Blue Shield of Minnesota Medicaid partnership, which is now scheduled for the first quarter of 2019. Despite this, the company reaffirmed all other full-year 2018 guidance metrics.
Key Highlights
- 1Reaffirmation of full-year 2018 net income guidance (greater than $14.46 per share, with adjusted net income greater than $15.60 per share).
- 2Reaffirmation of all other full-year 2018 guidance metrics, except for medical membership.
- 3Downward revision of expected 2018 year-end medical membership to approximately 39.5 million.
- 4Reason for membership revision: Delayed launch of Blue Cross Blue Shield of Minnesota Medicaid partnership to Q1 2019.
- 5Updated membership breakdown: Fully insured expected around 14.2 million, self-funded around 25.3 million.
- 6The information disclosed is intended for investor meetings occurring between November 29, 2018, and December 7, 2018.
- 7The filing includes standard forward-looking statement disclaimers, highlighting various risks and uncertainties that could affect future performance.